Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Ogino S, Chan AT, Fuchs CS, Giovannucci E.

Gut. 2011 Mar;60(3):397-411. doi: 10.1136/gut.2010.217182. Epub 2010 Oct 29. Review.

2.

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.

Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E.

Mod Pathol. 2013 Apr;26(4):465-84. doi: 10.1038/modpathol.2012.214. Epub 2013 Jan 11. Review.

3.

Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.

Ogino S, Lochhead P, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT.

Oncogene. 2014 Jun 5;33(23):2949-55. doi: 10.1038/onc.2013.244. Epub 2013 Jun 24. Review.

4.

Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.

Bae JM, Kim JH, Kang GH.

Histol Histopathol. 2013 May;28(5):585-95. doi: 10.14670/HH-28.585. Epub 2013 Jan 23. Review.

PMID:
23341177
5.

Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.

Kim JH, Kang GH.

World J Gastroenterol. 2014 Apr 21;20(15):4230-43. doi: 10.3748/wjg.v20.i15.4230. Review.

6.

Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer.

Sideris M, Papagrigoriadis S.

Anticancer Res. 2014 May;34(5):2061-8. Review.

PMID:
24778007
7.

Molecular classification and correlates in colorectal cancer.

Ogino S, Goel A.

J Mol Diagn. 2008 Jan;10(1):13-27. doi: 10.2353/jmoldx.2008.070082. Epub 2007 Dec 28. Review.

8.

Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer.

Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ.

Int J Mol Sci. 2017 Jan 19;18(1). pii: E197. doi: 10.3390/ijms18010197. Review.

9.

Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.

Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G, Fuchs CS, Ogino S.

J Pathol. 2010 Dec;222(4):350-66. doi: 10.1002/path.2774. Review.

10.

Methylator phenotype in colorectal cancer: A prognostic factor or not?

Gallois C, Laurent-Puig P, Taieb J.

Crit Rev Oncol Hematol. 2016 Mar;99:74-80. doi: 10.1016/j.critrevonc.2015.11.001. Epub 2015 Dec 7. Review.

PMID:
26702883
11.

Microsatellite instability in colorectal cancer: clinicopathological significance.

Setaffy L, Langner C.

Pol J Pathol. 2015 Sep;66(3):203-18. Review.

12.

Integration of molecular pathology, epidemiology and social science for global precision medicine.

Nishi A, Milner DA Jr, Giovannucci EL, Nishihara R, Tan AS, Kawachi I, Ogino S.

Expert Rev Mol Diagn. 2016;16(1):11-23. doi: 10.1586/14737159.2016.1115346. Epub 2015 Dec 4. Review.

13.

Cancer immunology--analysis of host and tumor factors for personalized medicine.

Ogino S, Galon J, Fuchs CS, Dranoff G.

Nat Rev Clin Oncol. 2011 Aug 9;8(12):711-9. doi: 10.1038/nrclinonc.2011.122. Review.

14.

[Epigenetic alterations in colorectal carcinomas and precancerous lesions].

Tischoff I, Tannapfel A.

Z Gastroenterol. 2008 Oct;46(10):1202-6. doi: 10.1055/s-2008-1027406. Epub 2008 Oct 20. Review. German.

PMID:
18937191
15.
16.

Four molecular subtypes of colorectal cancer and their precursor lesions.

Kang GH.

Arch Pathol Lab Med. 2011 Jun;135(6):698-703. doi: 10.1043/2010-0523-RA.1. Review.

PMID:
21631262
17.

Important molecular genetic markers of colorectal cancer.

Kudryavtseva AV, Lipatova AV, Zaretsky AR, Moskalev AA, Fedorova MS, Rasskazova AS, Shibukhova GA, Snezhkina AV, Kaprin AD, Alekseev BY, Dmitriev AA, Krasnov GS.

Oncotarget. 2016 Aug 16;7(33):53959-53983. doi: 10.18632/oncotarget.9796. Review.

18.
19.

Proceedings of the third international molecular pathological epidemiology (MPE) meeting.

Campbell PT, Rebbeck TR, Nishihara R, Beck AH, Begg CB, Bogdanov AA, Cao Y, Coleman HG, Freeman GJ, Heng YJ, Huttenhower C, Irizarry RA, Kip NS, Michor F, Nevo D, Peters U, Phipps AI, Poole EM, Qian ZR, Quackenbush J, Robins H, Rogan PK, Slattery ML, Smith-Warner SA, Song M, VanderWeele TJ, Xia D, Zabor EC, Zhang X, Wang M, Ogino S.

Cancer Causes Control. 2017 Feb;28(2):167-176. doi: 10.1007/s10552-016-0845-z. Epub 2017 Jan 17. Review.

PMID:
28097472
20.

Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.

Hamada T, Keum N, Nishihara R, Ogino S.

J Gastroenterol. 2017 Mar;52(3):265-275. doi: 10.1007/s00535-016-1272-3. Epub 2016 Oct 13. Review.

PMID:
27738762

Supplemental Content

Support Center